The present study dove deeper into the biology of the MYCN retinoblastoma subtype by correlating information of different molecular levels, defining MYCN-amplified RB1-proficient retinoblastoma as a unique retinoblastoma subtype with a distinct molecular background. This evidence concerns the gene MYCN and retinoblastoma.